Please login to the form below

Not currently logged in
Email:
Password:

licenses

This page shows the latest licenses news and features for those working in and with pharma, biotech and healthcare.

Pharma fears “lack of focus” on no-deal Brexit preparations

Pharma fears “lack of focus” on no-deal Brexit preparations

Industry has been making changes to supply chains, duplicating drug testing in the UK and EU27, transferring licenses and making plans to ship medicines to and from the UK on the

Latest news

More from news
Approximately 1 fully matching, plus 406 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    At the end of the studies Roche has the option to license the product whereupon it will take over the responsibility for further development and commercialisation of the product.

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    How long before Google or others license the data-gathering process and apply it to other geographies where such disparate silos of data are stored.

  • Licensing

  • Pharma deals continue to slide Pharma deals continue to slide

    This month, both AstraZeneca and Lilly have entered into technology platform discovery deals with an option to license. ... It is also good to see big pharma continuing to license out projects that are no longer of interest.

  • Deal Watch - May 2017 Deal Watch - May 2017

    Are multiple regional deals better than a global deal? It is usual for big pharma to license global rights but in some cases regional deals are preferred either by the licensor

More from intelligence
Approximately 1 fully matching, plus 45 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics